Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer. [electronic resource]
- Cancer chemotherapy and pharmacology 1983
- 108-12 p. digital
Publication Type: Journal Article
0344-5704
10.1007/BF00254257 doi
Adult Aged Bone Neoplasms--secondary Breast Neoplasms--drug therapy Cisplatin--adverse effects Drug Evaluation Female Humans Middle Aged